Increased Colorectal Cancer Screening Urged by Coalition

Share this content:
Boosting older adults' colorectal cancer screening rates to 80 percent by 2018 would lead to 21,000 fewer deaths.
Boosting older adults' colorectal cancer screening rates to 80 percent by 2018 would lead to 21,000 fewer deaths.

Boosting older adults' colorectal cancer screening rates to 80 percent by 2018 would lead to 21,000 fewer deaths from the cancer each year in the United States by 2030, according to research published in Cancer.

Colorectal cancer is a leading cause of cancer death in the United States. Yet in 2013, only 58 percent of American adults aged 50 to 75 underwent recommended screening for it, the study authors said.

An initiative to get four out of five older adults screened for colorectal cancer by 2018 was recently launched by the cancer roundtable, a coalition of public, private, and volunteer organizations.

Researchers used a computer model to estimate the potential benefits of 80 percent screening rates among adults aged 50 to 75.

RELATED: Vegetarian Diet May Lower Colorectal Cancer Risk

That level of screening would reduce colorectal cancer incidence rates by 17 percent and death rates by 19 percent by 2020. Over the long term, greater gains were predicted, with new cases and deaths declining 22 and 33 percent, respectively, from 2013 through 2030.

"The barriers to increasing colorectal cancer screening in the United States are significant and numerous," Richard Wender, M.D., chair of the National Colorectal Cancer Roundtable, said in a journal news release.

"But this study shows that investing in efforts to clear these hurdles will result in a major cancer prevention success."

Reference

  1. Meeser, Reinier G. S., MS, et al. "Public health impact of achieving 80% colorectal cancer screening rates in the United States by 2018." Cancer. DOI: 10.1002/cncr.29336. March 12, 2015.

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters